Gong Chao

Gong Chao is an accomplished professional in the field of bioanalysis, currently serving as Associate Director Integrated Bioanalysis at AstraZeneca since January 2024. Prior experience includes roles at Regeneron Pharmaceuticals, Inc., where Gong advanced from Staff Scientist to Senior Principal Scientist from June 2018 to January 2024, and served as a group leader overseeing increasing responsibilities. At NantOmics, LLC, from July 2015 to May 2018, Gong led clinical operations of an LC-MS CLIA lab as a Senior Scientist and conducted mass spectrometry analysis for clinical tissue samples. Gong began a postdoctoral position at Bristol-Myers Squibb in the Bioanalytical Science Department from October 2012 to November 2014. Educational qualifications include a PhD in Chemistry from Brown University (2006-2012) and a Bachelor in Chemistry from Nanjing University (2000-2004).